Rahman Md Ataur, Sarker Amily, Ayaz Mohammed, Shatabdy Ananya Rahman, Haque Nabila, Jalouli Maroua, Rahman M D Hasanur, Mou Taslin Jahan, Dey Shuvra Kanti, Hoque Apu Ehsanul, Zafar Muhammad Sohail, Parvez Md Anowar Khasru
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Global Biotechnology & Biomedical Research Network (GBBRN), Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia 7003, Bangladesh.
Biomedicines. 2024 Aug 5;12(8):1757. doi: 10.3390/biomedicines12081757.
Autophagy is a unique catabolic process that degrades irrelevant or damaged components in eukaryotic cells to maintain homeostasis and eliminate infections from pathogenesis. Pathogenic bacteria have developed many autophagy manipulation techniques that affect host immune responses and intracellular bacterial pathogens have evolved to avoid xenophagy. However, reducing its effectiveness as an innate immune response has not yet been elucidated. Bacterial pathogens cause autophagy in infected cells as a cell-autonomous defense mechanism to eliminate the pathogen. However, harmful bacteria have learned to control autophagy and defeat host defenses. Intracellular bacteria can stimulate and control autophagy, while others inhibit it to prevent xenophagy and lysosomal breakdown. This review evaluates the putative functions for xenophagy in regulating bacterial infection, emphasizing that successful pathogens have evolved strategies to disrupt or exploit this defense, reducing its efficiency in innate immunity. Instead, animal models show that autophagy-associated proteins influence bacterial pathogenicity outside of xenophagy. We also examine the consequences of the complex interaction between autophagy and bacterial pathogens in light of current efforts to modify autophagy and develop host-directed therapeutics to fight bacterial infections. Therefore, effective pathogens have evolved to subvert or exploit xenophagy, although autophagy-associated proteins can influence bacterial pathogenicity outside of xenophagy. Finally, this review implies how the complex interaction between autophagy and bacterial pathogens affects host-directed therapy for bacterial pathogenesis.
自噬是一种独特的分解代谢过程,可降解真核细胞中不相关或受损的成分,以维持体内平衡并消除致病过程中的感染。病原菌已发展出多种自噬操纵技术,影响宿主免疫反应,而细胞内病原菌也已进化出逃避异噬作用的机制。然而,作为一种先天性免疫反应,其有效性降低的原因尚未阐明。细菌病原体在受感染细胞中引发自噬,作为一种细胞自主防御机制来清除病原体。然而,有害细菌已经学会控制自噬并击败宿主防御。细胞内细菌可以刺激和控制自噬,而其他细菌则抑制自噬以防止异噬作用和溶酶体分解。本综述评估了异噬作用在调节细菌感染中的假定功能,强调成功的病原体已经进化出破坏或利用这种防御的策略,降低其在先天性免疫中的效率。相反,动物模型表明自噬相关蛋白在异噬作用之外影响细菌致病性。我们还根据目前改变自噬和开发宿主导向疗法以对抗细菌感染的努力,研究了自噬与细菌病原体之间复杂相互作用的后果。因此,尽管自噬相关蛋白可以在异噬作用之外影响细菌致病性,但有效的病原体已经进化出颠覆或利用异噬作用的能力。最后,本综述暗示了自噬与细菌病原体之间的复杂相互作用如何影响针对细菌发病机制的宿主导向疗法。